Evolution of SARS-CoV-2

Presented By: Kei Sato, PhD
Speaker Biography: Kei Sato is a Professor in The Institute of Medical Science, The University of Tokyo, Japan. His primary research focus is the interplay between viruses and hosts. In the last two years, he extensively focuses on the vilorogical characterization of SARS-CoV-2 variants. In March 2010, he got a Ph.D. (Medicine) in Institute for Virus Research, Kyoto University, Japan. By using a hematopoietic stem cell-transplanted "humanized" mouse model, he established a novel animal model for HIV infection, replication and pathogenesis. He also used a variety of mutant viruses and revealed the functional interplay between HIV-encoding proteins and antiviral host proteins in viral replication in vivo....
Webinar: Evolution of SARS-CoV-2
Webinar Abstract: At the end of 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), emerged in China. As of September 2022, SARS-CoV-2 is still ongoing pandemic: more than six hundred million cases of SARS-CoV-2 infection have been reported worldwide, with more than six million people dying of COVID-19. During the spreading worldwide, SARS-CoV-2 has been diversified, and these SARS-CoV-2 variants are considered to be the potential threats to the human society. In this talk, I will introduce our recent findings on a series of SARS-CoV-2 variants.
Earn PACE Credits:
1. Make sure you’re a registered member of Labroots (www.labroots.com/ms/webinar/e...)
2. Watch the webinar on CZcams or on the Labroots Website (www.labroots.com/ms/webinar/e...)
3. Click Here to get your PACE credits (Expiration date - October 19, 2024): (www.labroots.com/credit/pace-...)
Labroots on Social:
Facebook: / labrootsinc
Twitter: / labroots
LinkedIn: / labroots
Instagram: / labrootsinc
Pinterest: / labroots
SnapChat: labroots_inc